دورية أكاديمية
Proteomic Studies of Psoriasis.
العنوان: | Proteomic Studies of Psoriasis. |
---|---|
المؤلفون: | Sobolev VV; Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, 119334 Moscow, Russia., Soboleva AG; Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, 119334 Moscow, Russia.; Scientific Research Institute of Human Morphology, 117418 Moscow, Russia., Denisova EV; Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, 119334 Moscow, Russia.; Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, 119071 Moscow, Russia., Pechatnikova EA; Department of Dermatology and Cosmetology, Pirogov Russian National Research Medical University, 117997 Moscow, Russia., Dvoryankova E; Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, 119334 Moscow, Russia., Korsunskaya IM; Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, 119334 Moscow, Russia., Mezentsev A; Centre of Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, 119334 Moscow, Russia. |
المصدر: | Biomedicines [Biomedicines] 2022 Mar 07; Vol. 10 (3). Date of Electronic Publication: 2022 Mar 07. |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2013]- |
مستخلص: | In this review paper, we discuss the contribution of proteomic studies to the discovery of disease-specific biomarkers to monitor the disease and evaluate available treatment options for psoriasis. Psoriasis is one of the most prevalent skin disorders driven by a Th17-specific immune response. Although potential patients have a genetic predisposition to psoriasis, the etiology of the disease remains unknown. During the last two decades, proteomics became deeply integrated with psoriatic research. The data obtained in proteomic studies facilitated the discovery of novel mechanisms and the verification of many experimental hypotheses of the disease pathogenesis. The detailed data analysis revealed multiple differentially expressed proteins and significant changes in proteome associated with the disease and drug efficacy. In this respect, there is a need for proteomic studies to characterize the role of the disease-specific biomarkers in the pathogenesis of psoriasis, develop clinical applications to choose the most efficient treatment options and monitor the therapeutic response. |
References: | Adv Ther. 2020 May;37(5):2017-2033. (PMID: 32314303) Nat Protoc. 2009;4(4):484-94. (PMID: 19300442) Proteomics. 2018 Oct;18(19):e1800003. (PMID: 30094923) Hum Genomics Proteomics. 2009 Dec 08;2009:. (PMID: 20948568) Int J Mol Sci. 2020 Jul 28;21(15):. (PMID: 32731552) J Proteomics. 2019 Aug 15;205:103420. (PMID: 31229693) J Allergy Clin Immunol. 2017 Mar;139(3):923-932.e8. (PMID: 27502297) Clin Proteomics. 2015 Jan 13;12(1):1. (PMID: 25678896) JMIR Res Protoc. 2021 Sep 28;10(9):e28669. (PMID: 34581684) Mol Cell Proteomics. 2011 Jul;10(7):M111.009431. (PMID: 21742802) Skin Pharmacol Physiol. 2007;20(5):237-52. (PMID: 17587888) Sci Rep. 2021 Nov 2;11(1):21438. (PMID: 34728734) Theranostics. 2019 Apr 13;9(9):2475-2488. (PMID: 31131048) Sci Rep. 2019 Aug 6;9(1):11382. (PMID: 31388062) Genomics Proteomics Bioinformatics. 2015 Aug;13(4):224-33. (PMID: 26362816) Clin Proteomics. 2020 Aug 12;17:30. (PMID: 32817748) J Pharm Biomed Anal. 2018 Jun 5;155:185-193. (PMID: 29635173) J Invest Dermatol. 2018 Apr;138(4):775-784. (PMID: 29080680) J Invest Dermatol. 2011 Mar;131(3):677-87. (PMID: 21085185) Clin Exp Allergy. 2017 Nov;47(11):1456-1467. (PMID: 28703865) J Cutan Pathol. 2009 Dec;36(12):1255-61. (PMID: 19563493) J Rheumatol Suppl. 2020 Jun;96:19-24. (PMID: 32482763) J Proteome Res. 2007 Feb;6(2):662-71. (PMID: 17269723) J Proteomics. 2016 May 17;140:55-61. (PMID: 27063990) Exp Dermatol. 2019 Mar;28(3):317-321. (PMID: 30637808) Int J Biol Macromol. 2018 Oct 15;118(Pt B):1796-1810. (PMID: 30017989) Semin Cutan Med Surg. 2018 Feb;37(2S):S48-S51. (PMID: 29614138) J Am Acad Dermatol. 2021 Feb;84(2):370-380. (PMID: 32376430) Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2733-41. (PMID: 21852561) Sci Rep. 2020 Jan 17;10(1):605. (PMID: 31953524) J Transl Med. 2021 Aug 3;19(1):331. (PMID: 34344401) Rheumatology (Oxford). 2009 May;48(5):569-72. (PMID: 19273538) J Dermatol Sci. 2015 Sep;79(3):214-21. (PMID: 26055798) Int J Mol Sci. 2019 Mar 06;20(5):. (PMID: 30845706) J Pharm Biomed Anal. 2021 Oct 25;205:114359. (PMID: 34509137) Biomedicines. 2021 May 25;9(6):. (PMID: 34070542) J Proteomics. 2013 Dec 06;94:176-85. (PMID: 24061002) J Am Acad Dermatol. 2022 Feb;86(2):322-330. (PMID: 34339761) Genome Med. 2015 Aug 04;7(1):86. (PMID: 26251673) PLoS One. 2021 May 26;16(5):e0240956. (PMID: 34038424) Br J Dermatol. 2017 Aug;177(2):470-488. (PMID: 28129666) Hum Genet. 1999 Dec;105(6):523-9. (PMID: 10647885) N Engl J Med. 2005 May 5;352(18):1899-912. (PMID: 15872205) PLoS One. 2010 Dec 07;5(12):e15004. (PMID: 21165148) Rheumatology (Oxford). 2021 Feb 1;60(2):751-761. (PMID: 32793974) IEEE Trans Vis Comput Graph. 2010 Jul-Aug;16(4):609-20. (PMID: 20467059) Clin Drug Investig. 2018 Feb;38(2):101-112. (PMID: 29094282) J Pers Med. 2021 Sep 17;11(9):. (PMID: 34575702) J Invest Dermatol. 2019 Jan;139(1):100-107. (PMID: 30030151) Nucleic Acids Res. 2004 Jan 1;32(Database issue):D115-9. (PMID: 14681372) J Invest Dermatol. 2017 Feb;137(2):305-312. (PMID: 27667537) N Engl J Med. 2017 Mar 9;376(10):957-970. (PMID: 28273019) J Invest Dermatol. 2014 Jul;134(7):1828-1838. (PMID: 24441097) Semin Cutan Med Surg. 2018 Sep;37(3):134-142. (PMID: 30215629) J Eur Acad Dermatol Venereol. 2011 Jul;25(7):758-64. (PMID: 21198946) J Am Acad Dermatol. 2021 Apr;84(4):913-920. (PMID: 33259876) Front Immunol. 2018 Apr 05;9:579. (PMID: 29675020) Iran J Basic Med Sci. 2014 Sep;17(9):651-5. (PMID: 25691940) BMC Syst Biol. 2010 Apr 08;4:41. (PMID: 20377895) J Dermatol Sci. 2017 Jul;87(1):36-49. (PMID: 28431948) Int J Mol Med. 2011 Nov;28(5):785-92. (PMID: 21805023) Ann Rheum Dis. 2015 Mar;74(3):480-9. (PMID: 25561362) J Proteomics. 2021 May 30;240:104207. (PMID: 33798793) Stat Med. 2008 Dec 30;27(30):6547-69. (PMID: 18837075) Atherosclerosis. 2012 Aug;223(2):306-13. (PMID: 22770994) Clin Chem. 2008 Nov;54(11):1805-14. (PMID: 18801941) Proteomics Clin Appl. 2019 Jul;13(4):e1800119. (PMID: 30648813) Toxicol Lett. 2013 Aug 29;221(3):219-24. (PMID: 23830989) Immunity. 2013 Dec 12;39(6):1171-81. (PMID: 24332034) J Invest Dermatol. 2012 Nov;132(11):2552-64. (PMID: 22763790) Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):787-798. (PMID: 30760013) J Invest Dermatol. 2009 Dec;129(12):2795-804. (PMID: 19571819) J Invest Dermatol. 2018 Feb;138(2):273-281. (PMID: 28927890) Br J Dermatol. 2021 Jul 13;:. (PMID: 34254293) Rheum Dis Clin North Am. 2015 Nov;41(4):623-42. (PMID: 26476223) Nutrients. 2017 May 15;9(5):. (PMID: 28505128) Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1017-25. (PMID: 20149325) Cureus. 2020 Aug 11;12(8):e9651. (PMID: 32923251) J Invest Dermatol. 2005 Jan;124(1):63-9. (PMID: 15654954) Br J Dermatol. 2014 Jul;171(1):97-107. (PMID: 24601997) J Dermatolog Treat. 2019 Nov;30(7):648-658. (PMID: 30433838) Front Immunol. 2020 Jul 31;11:1432. (PMID: 32849499) Mol Cell. 2018 Jun 7;70(5):984. (PMID: 29883613) Sci Rep. 2017 Aug 18;7(1):8707. (PMID: 28821884) Electrophoresis. 1995 Jul;16(7):1090-4. (PMID: 7498152) Methods Mol Biol. 2016;1450:213-21. (PMID: 27424757) PLoS One. 2012;7(10):e46571. (PMID: 23082126) Lancet. 2015 Aug 8;386(9993):552-61. (PMID: 26051365) |
فهرسة مساهمة: | Keywords: LC-MS/MS; SOMAscan™; biomarkers; comorbidities; mass spectrometry; predisposition; proximity extension assay; psoriasis; risk factors |
تواريخ الأحداث: | Date Created: 20220325 Latest Revision: 20220329 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC8945259 |
DOI: | 10.3390/biomedicines10030619 |
PMID: | 35327421 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!